Lansoprazole Delayed-Release Capsules USP — Class II drug recall D-0438-2024
Terminated recall by NATCO Pharma Limited, reported 2024-04-17, distributed nationwide. CGMP Deviations
| Recall number | D-0438-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | NATCO Pharma Limited, Rangareddy, N/A, India |
| Recall initiated | 2024-03-27 |
| Classified | 2024-04-05 |
| Reported by FDA | 2024-04-17 |
| Terminated | 2026-02-06 |
| Distributed | Nationwide (US) |
| Quantity | 30 bottles |
| Reason classes | cgmp |
| NDC | 16571-0742-41 |
| Lot numbers | 411988 |
| Expiration dates | 2025-05-31 |
Product
Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0438-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.